Consolidative Radiotherapy for Limited Metastatic Non–Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial

By P. Iyengar, Z. Wardak, D. Gerber, V. Tumati, C. Ahn, R. Hughes, J. Dowell, N. Cheedella, L. Nedzi, K. Westover and 3 more. JAMA Oncology, 2018

929 citations recorded by the source corpus.

Subfields: Hepatology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/5452e3512e1eefcb2c2bd3539eb38d4f75c1f9c2

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. D. Planchard
2. S. Popat
3. K. Kerr
4. S. Novello
5. E. Smit
6. C. Faivre-Finn
7. M. Hellmann
8. T. Mok

Citations in the corpus

• Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2018, background): “The second study randomised patients with 5 metastatic sites between maintenance ChT alone versus SABR followed by maintenance ChT (n1⁄4 29) [312].”
• Twitter (2020, neutral): “tweets, median (IQR) 0 (0-1) 2 (2-10) 3 (1-9) 17 (3-46) 2 (0-7) < 0.”